Paras Healthcare Limited’s Government Payers Lead Revenue Mix

Paras Healthcare Limited, operating under the Paras Health brand, received 43.63% of revenue from operations from government schemes and public sector undertakings (PSUs) in the three months ended June 30, 2026. Government-funded care was the largest payer category, 12.33 percentage points above self-pay’s 31.30% share, as bed occupancy reached 69.72%.

Why did government schemes and PSUs become Paras Health’s largest payer?

Government schemes and PSUs became Paras Health’s largest payer because they accounted for 43.63% of revenue from operations in the June 2026 quarter, ahead of self-pay at 31.30% and insurance or third-party administrator arrangements at 25.07%. The three reported categories totalled 100% of the company’s revenue from operations for the period.

Paras Health defines government schemes and PSUs as revenue from government programmes, including public healthcare schemes, subsidies and employee-welfare schemes in government departments, which cover eligible patients’ care costs. Self-pay covers domestic and international patients who settle bills directly and are not covered by insurance, third-party administrator, corporate-credit or government-sponsored arrangements. Insurance or third-party administrator, known as TPA, revenue includes cashless treatment and corporate-credit arrangements.

The June 2026 mix put government schemes and PSUs 12.33 percentage points ahead of self-pay. Insurance and TPA arrangements were the smallest reported payer category at 25.07%. For government schemes and PSUs to remain the largest category, their revenue contribution would need to stay above the self-pay share in later reporting periods.

How quickly has Paras Health’s government payer revenue mix changed?

Paras Health’s government schemes and PSU revenue share rose by 13.87 percentage points from 29.76% in Fiscal 2024 to 43.63% in the three months ended June 30, 2026. Across the same comparison, self-pay declined by 9.33 percentage points from 40.63% to 31.30%, while insurance and TPA revenue fell by 4.54 percentage points from 29.61% to 25.07%.

The largest annual movement was between Fiscal 2025 and Fiscal 2026, when the government and PSU share increased by 10.37 percentage points to 41.28%. The share then increased by 5.57 percentage points year on year in the June 2026 quarter, from 38.06%. In contrast, self-pay fell by 7.13 percentage points between Fiscal 2025 and Fiscal 2026 and by 2.97 percentage points year on year in the June quarter.

The payer-mix change coincided with a larger contribution from Tier-2 cities, which Paras Health defines as all hospitals other than Gurugram. Tier-2 city revenue represented 69.64% of revenue from operations in the June 2026 quarter, compared with 64.99% in the June 2025 quarter and 62.35% in Fiscal 2024. The disclosure does not allocate government-scheme and PSU revenue by hospital or city.

How does Paras Health compare with peers on government payer revenue?

Paras Health reported the highest disclosed government schemes and PSU share in the June 2026 peer comparison. Its 43.63% share was 22.73 percentage points above Max Healthcare Institute Ltd’s 20.90%, the next-highest reported share, and 22.93 percentage points above Fortis Healthcare Ltd’s 20.70%.

Government schemes and PSUs were not the leading reported payer category for Aster DM Quality Care, Apollo Hospitals, Fortis Healthcare, Global Health, Jupiter Lifeline, Krishna Institute, Max Healthcare or Narayana Hrudayalaya in the June 2026 comparison. Manipal Health Enterprises did not report a comparable payer split in the table. Paras Health also notes that peer disclosures may apply different methods and formulae, so the figures may not be strictly comparable.

What operating and financial results coincided with the payer shift?

Paras Health’s higher government and PSU share coincided with higher hospital utilisation, revenue and earnings before interest, tax, depreciation and amortisation, or EBITDA, in the June 2026 quarter. Bed occupancy, calculated as periodic average occupied beds divided by periodic average operational beds, rose to 69.72% from 56.75% a year earlier. Operational beds increased to 1,502 from 1,465, while total bed capacity increased to 2,211 from 2,135.

Revenue from operations rose 27.66% year on year to Rs 470.278 crore in the three months ended June 30, 2026, from Rs 368.387 crore in the corresponding prior-year period. EBITDA, calculated by Paras Health as profit before tax plus finance costs and depreciation and amortisation expense, increased 71.13% to Rs 113.477 crore from Rs 66.309 crore. EBITDA margin, calculated as EBITDA divided by total income, increased to 23.70% from 17.72%.

The disclosure does not attribute the increase in revenue or EBITDA to a specific payer category. However, patient activity also increased in the June 2026 quarter: in-patient volume rose to 34,354 from 26,362, while out-patient volume rose to 225,734 from 178,977. Average revenue per occupied bed, or ARPOB, was Rs 49,351.70 per day, compared with Rs 48,663.65 per day a year earlier, and average length of stay declined to 2.77 days from 2.87 days.

Conclusion

Paras Health moved from self-pay leadership in Fiscal 2024 and Fiscal 2025 to government schemes and PSU leadership in the three months ended June 30, 2026. The 43.63% government and PSU share was the highest level disclosed for the periods shown and occurred alongside 69.72% occupancy, Rs 470.278 crore in revenue from operations and a 23.70% EBITDA margin.

The next reported measure is whether government schemes and PSUs remain above self-pay while occupancy, ARPOB and patient volumes change. Paras Health has said it will disclose the stated key performance indicators periodically, at least annually or at a shorter interval decided by its board, until the later of one year after listing or complete utilisation of offer proceeds, subject to applicable regulations.